Sign in

NCT07442500Not yet recruiting

Drug Coated Balloon vs. Drug-eluting Stent in Patients With Coronary Artery Disease

Source: ClinicalTrials.gov · Last updated 2 Mar 2026

Brief summary (registry, in English)

Studies exploring the feasibility of drug-eluting balloon (DCB) in de-novo coronary lesions are limited. There are scarce data comparing DCB with drug-eluting stent (DES) in patients with high bleeding risk (HBR), a situation in which long-term maintenance of dual antiplatelet therapy (DAPT) is a clinical dilemma. This target trial emulation aims to compare clinical outcomes between DCB angioplasty and conventional DES implantation in de-novo coronary lesions in patients with coronary artery disease.

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
470000 (estimated)
First submitted
24 Feb 2026
Start date
28 Feb 2026
Primary completion date
30 Jun 2026
Lead sponsor
Samsung Medical Center
NCT number
NCT07442500

What you commit to

  • Study type: Observational
  • Planned participants: 470000
  • From 28 Feb 2026 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous revascularization procedure before index percutaneous coronary intervention

Other

  • Hybrid strategy (DCB and DES use)
  • Failed percutaneous coronary intervention

Who the study is looking for

  • Patients with coronary artery disease undergoing percutaneous coronary intervention
  • Used devices number less than three (relatively simple lesion)

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Samsung Medical Center
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.